10.5 million investments for the research in the biomedical sector 10.5 million investments for the research in the biomedical sectorItelPharma2017-01-02T09:38:58+01:00Monday, January 2, 2017|Read More
10.5 million investments for the research in the biomedical sector 10.5 million investments for the research in the biomedical sectorItelPharma2017-01-02T09:38:58+01:00Monday, January 2, 2017|Read More
10.5 million investments for the research in the biomedical sector 10.5 million investments for the research in the biomedical sectorItelPharma2017-01-02T09:38:58+01:00Monday, January 2, 2017|Read More
10.5 million investments for the research in the biomedical sector 10.5 million investments for the research in the biomedical sectorItelPharma2017-01-02T09:38:58+01:00Monday, January 2, 2017|Read More
Arabs take lessons from Itel’s nuclear medicine Arabs take lessons from Itel’s nuclear medicineItelPharma2016-11-03T09:34:48+01:00Thursday, November 3, 2016|Read More
Arabs take lessons from Itel’s nuclear medicine Arabs take lessons from Itel’s nuclear medicineItelPharma2016-11-03T09:34:48+01:00Thursday, November 3, 2016|Read More
Arabs take lessons from Itel’s nuclear medicine Arabs take lessons from Itel’s nuclear medicineItelPharma2016-11-03T09:34:48+01:00Thursday, November 3, 2016|Read More
Second production line and four new molecules for Itelpharma Second production line and four new molecules for ItelpharmaItelPharma2016-10-31T09:32:59+01:00Monday, October 31, 2016|Read More
Second production line and four new molecules for Itelpharma Second production line and four new molecules for ItelpharmaItelPharma2016-10-31T09:32:59+01:00Monday, October 31, 2016|Read More
Second production line and four new molecules for Itelpharma Second production line and four new molecules for ItelpharmaItelPharma2016-10-31T09:32:59+01:00Monday, October 31, 2016|Read More
